Synapse - law for life sciences - April 2018

This month on Synapse

European Commission's 8th Report on the monitoring of patent settlements

Amanda Ebbutt and Louisa Penny report the findings of the European Commission's 8th Report on the monitoring of patent settlements in the pharmaceutical sector.

Topical issues

Bolar and the experimental use exemptions in the UK

Paul England explains how there are three exemptions in the UK that potentially apply to patent infringement by life sciences products.

General Court considers requirements for designation as an orphan medicinal product

Belinda Lavin considers a recent General Court decision concerning the requirements for designation of a medicinal product as an orphan medicinal product.

Brexit and the life sciences: April 2018 update

Matthew Royle and Paul England discuss the impact that the draft Brexit withdrawal and transition arrangements have on life sciences products.

The UPC and Unitary Patent: April 2018 update

Sara Burghart and Paul England discuss the latest status in the UK and Germany of the ratification of the Unified Patent Court and Unitary Patent.

Visit Synapse